rs74315205
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_006005.3(WFS1):c.2590G>A(p.Glu864Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 35)
Consequence
WFS1
NM_006005.3 missense
NM_006005.3 missense
Scores
9
6
4
Clinical Significance
Conservation
PhyloP100: 9.17
Genes affected
WFS1 (HGNC:12762): (wolframin ER transmembrane glycoprotein) This gene encodes a transmembrane protein, which is located primarily in the endoplasmic reticulum and ubiquitously expressed with highest levels in brain, pancreas, heart, and insulinoma beta-cell lines. Mutations in this gene are associated with Wolfram syndrome, also called DIDMOAD (Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness), an autosomal recessive disorder. The disease affects the brain and central nervous system. Mutations in this gene can also cause autosomal dominant deafness 6 (DFNA6), also known as DFNA14 or DFNA38. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PM1
In a topological_domain Lumenal (size 216) in uniprot entity WFS1_HUMAN there are 92 pathogenic changes around while only 24 benign (79%) in NM_006005.3
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.976
PP5
Variant 4-6302385-G-A is Pathogenic according to our data. Variant chr4-6302385-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 4526.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-6302385-G-A is described in Lovd as [Pathogenic]. Variant chr4-6302385-G-A is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WFS1 | NM_006005.3 | c.2590G>A | p.Glu864Lys | missense_variant | 8/8 | ENST00000226760.5 | NP_005996.2 | |
WFS1 | NM_001145853.1 | c.2590G>A | p.Glu864Lys | missense_variant | 8/8 | NP_001139325.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WFS1 | ENST00000226760.5 | c.2590G>A | p.Glu864Lys | missense_variant | 8/8 | 1 | NM_006005.3 | ENSP00000226760 | P2 | |
ENST00000661896.1 | n.1337+1530C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 35
GnomAD3 genomes
Cov.:
35
GnomAD4 exome Cov.: 87
GnomAD4 exome
Cov.:
87
GnomAD4 genome Cov.: 35
GnomAD4 genome
Cov.:
35
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal dominant nonsyndromic hearing loss 6 Pathogenic:3Other:1
Pathogenic, no assertion criteria provided | research | Laboratory of Prof. Karen Avraham, Tel Aviv University | May 07, 2018 | Dominant, postlingual, moderate-profound HL, U-shaped audiogram - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2008 | - - |
Pathogenic, no assertion criteria provided | research | Laboratory of Prof. Karen Avraham, Tel Aviv University | Feb 19, 2016 | Comgenital, low-tone, U-shaped HL - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 06, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 21917145, 34416374, 31389194, 29511163, 34997062, 16648378, 26346818, 29529044, 31600780, 17492394, 32567228, 33841295, 18544103, 28271504) - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 864 of the WFS1 protein (p.Glu864Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant Wolfram-like syndrome and nonsyndromic deafness (PMID: 16648378, 17492394, 21917145, 29529044). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4526). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on WFS1 protein function. For these reasons, this variant has been classified as Pathogenic. - |
Wolfram-like syndrome Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 01, 2008 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Apr 05, 2022 | - - |
Nonsyndromic genetic hearing loss Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | INGEBI, INGEBI / CONICET | Jul 15, 2021 | Based on ACMG/AMP guidelines and Hearing Loss Expert Panel specific criteria::The c.2590 G>A variant (p.Glu864Lys) in WFS1 gene is absent in gnomAD population database meeting PM2. This variant has been identified in six probands with familial autosomal sensorineural hearing loss and the variant segregated correctly in the affected memebers of different families applying to PS4_Mod and PP1_Mod (PMID:16648378, 17492394, 20301750, 21917145, this report). In two familial cases some affected relatives presented optic atrophy and diabetes with variable onset and severity in adittion to hearing impairment. Since hearing loss is the constant feature, the other evidence sypmton is not considered. Computational evidence predicted a pathogenic impacto of the mutation to the protein (PP3). Considering all the information: PM2, PS4_Mod, PP1_Mod and PP3 the c.2590 G>A variant is classified as Likely Pathogenic for autosomal dominant hearing loss (affecting predominantly low frequencies). - |
Wolfram syndrome 1 Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics Laboratory, University Hospital Schleswig-Holstein | May 27, 2021 | - - |
Rare genetic deafness Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 05, 2021 | The p.Glu864Lys or c.2590G>A variant in WFS1 has been reported in ten probands with autosomal dominant hearing loss, including three families with Wolfram-like syndrome and one de novo proband. The variant segregated with disease in 15 affected individuals from eight families (Eiberg 2006 PMID: 16648378, Fukuoka 2007 PMID: 17492394, Valero 2008 PMID: 18544103, Brownstein 2011 PMID: 21917145, Moteki 2011 PMID: 26346818, Kobayashi 2018 PMID: 29529044, Guan 2020 PMID: 32567228, LMM data). It was absent from large population studies. Computational prediction tools and conservation analyses suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant hearing loss. ACMG/AMP Criteria applied: PS2, PP1_Strong, PM2, PS4_Moderate, BP4. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
A;A
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Pathogenic
Sift
Benign
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MutPred
Gain of MoRF binding (P = 0.0016);Gain of MoRF binding (P = 0.0016);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at